Insider tradingForm 4
Monopar Therapeutics (MNPR) Insider Trading
5 open-market trades reported since Aug 27, 2026: 0 purchases worth $0 and 5 sales worth $4.02M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Christopher M. Starr | Director | 0 | $0 | 1 | $659K |
| Chandler Robinson | CEO | 0 | $0 | 1 | $2.56M |
| Kim R. Tsuchimoto | Director | 0 | $0 | 1 | $456K |
| Raymond Anderson | Director | 0 | $0 | 1 | $351K |
| Patrice Rioux | Other | 0 | $0 | 1 | $111 |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 5 | Christopher M. StarrDirector | ▼ SELL10b5-1 | $659K | |
| Sep 28 | Chandler RobinsonCEO | ▼ SELL10b5-1 | $2.56M | |
| Aug 27 | Kim R. TsuchimotoDirector | ▼ SELL10b5-1 | $456K | |
| Aug 27 | Raymond AndersonDirector | ▼ SELL10b5-1 | $351K | |
| Aug 27 | Patrice RiouxOther | ▼ SELL10b5-1 | $111 |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings